Tumor tissues were taken for immunofluorescence staining of CD3+ CD8+ T cells (Fig. 5A), and the MAC group was able to increase the level of CD3+ CD8+ T cells in the tumors, but fewer immune cells were activated, and the tumor immunotherapy capacity was low. The gene discussed is CD8A; the disease is neoplasm.